EllumGet notified

CJC-1295 / ipamorelin stack: what's in it

By Ellum EditorialPublished Updated AI use

The short answer

CJC-1295 / ipamorelin stack combines CJC-1295 and Ipamorelin.

  • What it is

    Pairs a GHRH analog with a GH secretagogue, two signals linked to GH release.

  • What people look into

    Muscle and exercise, aging, sleep

    Results for one compound don't tell you what the two do together.

The parts

  • CJC-1295 Index

    Not FDA-approved

    WADA 2026: S2.2.4

    Papers on animals5
    Lab-dish (cell) papers1
    Papers PubMed tags as about people20
    Registered trials (ClinicalTrials.gov)1
    Randomized trials in people1

  • Ipamorelin Index

    Not FDA-approved

    WADA 2026: S2.2.4

    Papers on animals20
    Lab-dish (cell) papers1
    Papers PubMed tags as about people22
    Registered trials (ClinicalTrials.gov)2 of 3 search results name Ipamorelin
    Randomized trials in people2

Bars are counts of papers or trials; a longer bar means more studies, not better results. Study counts auto-counted from PubMed tags and ClinicalTrials.gov in the Ellum research database, as of October 6, 2026 (not reviewed; a paper can carry more than one tag). Papers PubMed tags as about people: includes reviews and case reports; not randomized trials. All bars share one scale. Each count is for that part alone.

Regulatory status by component

Not FDA-approved How we label status

Status as of October 4, 2026

As a combination
Neither component has a 503A category (both withdrawn 2024-09-27); ipamorelin acetate is in 503B Category 2
PCAC
Components each voted against: ipamorelin 2024-10-29, CJC-1295 2024-12-04
  • CJC-1295: as of October 4, 2026 · source
  • Ipamorelin: as of October 4, 2026 · source

Timeline

Scroll sideways to see all columns.

DateWhat happenedSource
U.S. Attorney's Office for the District of Utah press release on an indictment lists Ipamorelin and CJC 1295 among peptides allegedly obtained from China and sold to patients.Government source
FDA lists ipamorelin acetate in category 2 for outsourcing facilities (503B, added September 29, 2023) and CJC-1295 among bulk drug substances nominated but withdrawn, on its page of bulk drug substances that may present significant safety risks in compounding (content current as of 2026-04-22).FDA

Get updates on CJC-1295 / ipamorelin stack

We'll store your email, your state, the page you're on and the peptides selected below (pre-selected from this page; untick any). Together these can reveal health interests. We use them only for what you tick below and to count sign-ups by state and peptide, without emails, to plan where the clinic opens and for reports that show only totals. Our hosting, database and email providers handle them for us. We pass them to a doctor or clinic only if you tick that box, and we don't sell them. Withdraw anytime with the unsubscribe link or at hello@ellumclinic.com. Consumer Health Data Privacy Policy

Ellum's sign-ups are for adults 18 and over.

Peptides: CJC-1295 / ipamorelin stack (1 selected) · edit
Peptides you're interested in
What we may email you about
More options (optional): research, doctor contact, paid offers

The research on CJC-1295 / ipamorelin stack

Key facts

Also known as: cjc ipamorelin, cjc/ipamorelin, cjc ipa stack, cjc-1295 ipamorelin blend

Parts
CJC-1295 and Ipamorelin
Route
injectable

References

Status sources

Sources as of October 4, 2026

  1. FDA: www.fda.gov/media/185642/download
  2. FDA: www.fda.gov/media/185412/download
  3. FDA: www.fda.gov/media/94155/download
  4. FDA: www.fda.gov/media/94164/download
  5. WADA: www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
  6. Internet Archive: web.archive.org/web/20241107074712id_/https://www.fda.gov/media/94155/download

What this doesn’t establish

Results for one compound don't tell you what the two do together.